Masataka Kuwana

Tokyo, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 389 publications

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

JCS/JPCPHS 2025 Guideline on Pulmonary Hypertension and Pulmonary Embolism/Deep Vein Thrombosis.

Journal: Circulation journal : official journal of the Japanese Circulation Society

Published: July 01, 2026

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Lower-dose glucocorticoid therapy achieves comparable outcomes in Japanese patients with lupus nephritis.

Journal: Lupus

Published: May 06, 2026

Transcriptomic profiling of myocardial biopsies reveals metabolic suppression and autophagy activation in systemic sclerosis-associated primary heart involvement.

Transcriptomic profiling of myocardial biopsies reveals metabolic suppression and autophagy activation in systemic sclerosis-associated primary heart involvement.

Journal: Journal of scleroderma and related disorders

Published: April 08, 2026

Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies.

Critical ischemia of multiple organ systems in a patient with systemic lupus erythematosus complicated by catastrophic antiphospholipid syndrome: Potential pathogenetic role of non-inhibitory anti-ADAMTS13 autoantibodies.

Journal: Modern rheumatology case reports

Published: March 26, 2026

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Cancer in systemic sclerosis: clinical associations and prognostic impact from the EUSTAR registry.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 25, 2026

Baseline disease activity index and forced vital capacity predict clinically meaningful complications and mortality in systemic sclerosis.

Baseline disease activity index and forced vital capacity predict clinically meaningful complications and mortality in systemic sclerosis.

Journal: Rheumatology (Oxford, England)

Published: March 15, 2026

Post-marketing surveillance of fostamatinib for primary immune thrombocytopenia in Japan: interim analysis.

Post-marketing surveillance of fostamatinib for primary immune thrombocytopenia in Japan: interim analysis.

Journal: International journal of hematology

Published: March 05, 2026

Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis.

Phenotype-specific associations of mosaic chromosomal alterations in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: February 27, 2026

High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis.

High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis.

Journal: Annals of the rheumatic diseases

Published: February 20, 2026

Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.

Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.

Journal: Modern rheumatology

Published: February 13, 2026

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Interlaboratory variability in laboratory testing and reporting of myositis autoantibodies.

Journal: Journal of autoimmunity

Published: February 12, 2026

Cellular therapies in systemic Sclerosis: immunopathogenesis-informed precision targeting with CAR-T and CAR-NK approaches.

Cellular therapies in systemic Sclerosis: immunopathogenesis-informed precision targeting with CAR-T and CAR-NK approaches.

Journal: Best practice & research. Clinical rheumatology

Published: February 12, 2026

Showing 1-12 of 389

Last Updated: 09/26/2026